In Japan, the “First edition of Clinical practice guidelines for the diagnosis and management of acute otitis media (AOM) in children in Japan” was published in 2006. Three novel antibiotic drags (CVA/AMPC, TBPM-PI, and TFLX) were placed on the market from 2006 to 2010, and the protein-conjugated pneumococcal vaccine (PCV) was introduced in 2010. The objective of this study was to assess the current incidence of intractable AOM in young children. The subjects were 204 patients (age 0 to 5, 124 boys, 80 girls) who were hospitalized in the Department of Otorhinolaryngology of National Mie Hospital between January 2000 and December 2014 because of AOM. We conducted a retrospective study of the charts of these patients. Fifty patients who underwent ventilation tube insertion (VTI) due to recurrent otitis media in the same period were also analyzed. In the patients hospitalized because of AOM, 58.8% of them were one-year old children and 87.8% were in day care and/or had siblings. Between 2000 and 2014, which was divided into three periods (2000-2005, 2006-2010, and 2011-2014), the number of inpatients significantly decreased. Children aged one and two years admitted to the hospital also significantly decreased. The number of
Streptococcus pneumoniae isolated from the middle ear or nasopharynx significantly decreased during the same periods. There were no significant changes in the number of
Haemophilus influenzae. The number of patients who underwent VTI did not significantly decrease during the study period. We conclude that intractable AOM in young children is decreasing rapidly in these past several years. There is a possibility that the newly developed antibiotics and PCV are playing an important role in the decline.
View full abstract